Primary parotid lymphoma from a regional cancer center in South India
Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is limited data in Indian population. Hence we undertook this retrospective observational study of primary parotid lymphoma at our centre...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and
comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is
limited data in Indian population. Hence we undertook this retrospective observational study
of primary parotid lymphoma at our centre in Southern India.
Results: 7 consecutive cases diagnosed as PPL by tissue biopsy/superficial/deep
parotidectomy confirmed by immunohistochemistry between 2007 and 2012 were included.
Median age was 54 years(29-78), and it was more common in males. Diffuse large B cell
lymphoma was seen in 6 and extra nodal marginal zone lymphoma in 1. According to Ann
Arbor stage- Advanced stage (stage III and IV) was seen in 2(28.57%). According to the
International Prognostic Index most were in low risk- 6 (85.7%). Overall survival range from
1-45 months, with a median survival of 24 months.
Conclusions: To conclude, PPL presents more often in early stage and low IPI score. Surgery
with chemoimmunotherapy with involved field radiotherapy remains the standard treatment
at present. |
|---|---|
| ISSN: | 2035-3006 |